NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
James Lefevre
Vanderbilt University - Nashville / United States
Others
AD Scientific Index ID: 5337250
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James Lefevre's MOST POPULAR ARTICLES
1-)
Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature reviewJD LeFevre, SL Cyriac, A Tokmic, JM PitlickAmerican Journal of Health-System Pharmacy 79 (23), 2099-2117, 2022142022
2-)
Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney DiseaseS Bayne, J LeFevre, K Olstinske, S Ravindran, S MunusamyAdvanced Biology 8 (3), 2300496, 20242024
3-)
Low-Dose Metformin Treatment Offers Modest Nephroprotection in a Mouse Model of Diabetic Kidney DiseaseK Olstinske, J LeFevre, C Karch, R Frantz, K Carvendale, S MunusamyJournal of Pharmacology and Experimental Therapeutics 385 (S3), 20232023
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept